Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Boehringer Ingelheim
Express Scripts
Fuji
Novartis
Healthtrust
Baxter
Chinese Patent Office
McKesson
Deloitte

Generated: August 20, 2017

DrugPatentWatch Database Preview

Brompheniramine maleate; pseudoephedrine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for brompheniramine maleate; pseudoephedrine hydrochloride and what is the scope of brompheniramine maleate; pseudoephedrine hydrochloride patent protection?

Brompheniramine maleate; pseudoephedrine hydrochloride
is the generic ingredient in one branded drug marketed by Alza and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for brompheniramine maleate; pseudoephedrine hydrochloride.

Summary for Generic Name: brompheniramine maleate; pseudoephedrine hydrochloride

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Drug Master File Entries: see list21
Clinical Trials: see list2,463
Drug Prices:see low prices
DailyMed Link:brompheniramine maleate; pseudoephedrine hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alza
EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE
brompheniramine maleate; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL019672-001Mar 29, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: brompheniramine maleate; pseudoephedrine hydrochloride

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Chubb
Federal Trade Commission
Medtronic
Cerilliant
Queensland Health
Novartis
Colorcon
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot